Clinical Trial Update: Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR) [Phase 1]

View source ↗

Summary

A Phase 1 study assessed bioequivalence between two 25 mg tablets and one 50 mg sustained-release desvenlafaxine under fasted and fed conditions, and evaluated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• DVS SR

Snippet

Sponsor: Pfizer | Conditions: Depression - Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2012-01-27